,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-05-18 07:13:00,Many conservative investors gravitate toward blue-chip dividend stocks with healthy yields well above what the overall market pays.,0.6332884430885315,0.01935063675045967,0.3473609685897827,positive,0.6139377951622009
1,2018-05-18 07:13:00,"Right now, the market average of about 2% isn't all that much for income-hungry investors, especially as bond rates start to rise more sharply.",0.30535730719566345,0.06621680408716202,0.6284258365631104,neutral,0.23914051055908203
2,2018-05-18 07:13:00,"Fortunately, you can find a number of solid investment choices within the Dow Jones Industrials (DJINDICES: ^DJI) that yield 3% or more.",0.7721696496009827,0.013930808752775192,0.21389949321746826,positive,0.7582388520240784
3,2018-05-18 07:13:00,"Among them are Chevron (NYSE: CVX) , Procter & Gamble (NYSE: PG) , and Merck (NYSE: MRK) .",0.022804971784353256,0.0064907013438642025,0.9707042574882507,neutral,0.016314269974827766
4,2018-05-18 07:13:00,"Each of them faces challenges that could present difficulties in the short run, but they've demonstrated an ability to overcome adversity and produce long-term growth.",0.8797308206558228,0.012597168795764446,0.10767211019992828,positive,0.8671336770057678
5,2018-05-18 07:13:00,Chevron has a good reputation for paying dividends.,0.4762750267982483,0.010729450732469559,0.5129955410957336,neutral,0.46554556488990784
6,2018-05-18 07:13:00,"Not only does the oil giant have a yield of 3.6% right now, it's also made annual dividend increases for more than 30 years.",0.7686125636100769,0.01348347868770361,0.2179040014743805,positive,0.7551290988922119
7,2018-05-18 07:13:00,"The most recent boost came earlier this year, taking the quarterly payout up by 4% to $1.12 per share.",0.9505782723426819,0.021982785314321518,0.027438966557383537,positive,0.9285954833030701
8,2018-05-18 07:13:00,Many oil companies have had to adjust to lower crude prices by finding ways to enhance production rates by adding to their assets.,0.8084723353385925,0.024205580353736877,0.1673220694065094,positive,0.7842667698860168
9,2018-05-18 07:13:00,"Yet at least so far, Chevron has avoided that strategic direction , instead focusing its efforts on cost reduction and making the most of its current production assets.",0.0474657379090786,0.23703451454639435,0.715499758720398,neutral,-0.18956877291202545
10,2018-05-18 07:13:00,"Chevron isn't giving up on strategic acquisitions and other investments, but anticipated annual spending levels of $18 billion to $20 billion aren't nearly as large as they might seem for a company its size.",0.15912415087223053,0.05827397108078003,0.7826018929481506,neutral,0.1008501797914505
11,2018-05-18 07:13:00,"With the recent rise in oil prices , Chevron's bigger bet on the long-term promise of various shale plays across the U.S. could pay off without nearly as big a shift in its business model.",0.8987360596656799,0.030374711379408836,0.07088927179574966,positive,0.8683613538742065
12,2018-05-18 07:13:00,And that could prove to be the best possible outcome for this global oil giant.,0.826412558555603,0.01769808493554592,0.1558893620967865,positive,0.8087144494056702
13,2018-05-18 07:13:00,Dividend investors know that businesses focusing on consumer goods can be cash cows.,0.12630827724933624,0.014969553798437119,0.8587222099304199,neutral,0.11133871972560883
14,2018-05-18 07:13:00,Procter & Gamble's track record of annual dividend increases is over 60 years long.,0.5911812782287598,0.009851709939539433,0.3989669978618622,positive,0.5813295841217041
15,2018-05-18 07:13:00,And its current dividend yield of almost 4% shows that the company behind products like Tide laundry detergent and Pampers diapers isn't skimping on its payouts.,0.4774901568889618,0.28579607605934143,0.23671381175518036,positive,0.19169408082962036
16,2018-05-18 07:13:00,Some investors aren't entirely comfortable with the fact that the pace of P&G's dividend growth has slowed in recent years.,0.03629324957728386,0.9197933077812195,0.04391341283917427,negative,-0.8835000395774841
17,2018-05-18 07:13:00,"After a long period of double-digit-percentage annual increases, boosts since 2015 have been in the 1% to 4% range, culminating with its increase earlier this spring .",0.9068016409873962,0.0180561114102602,0.07514223456382751,positive,0.8887455463409424
18,2018-05-18 07:13:00,"That reflects some of the difficulties that Procter & Gamble has seen in maintaining the pace of sales growth that it would like, with its fiscal second-quarter results in April having shown only a 1% rise in organic sales.",0.42885157465934753,0.472800076007843,0.09834835678339005,negative,-0.04394850134849548
19,2018-05-18 07:13:00,"Yet with moves like improved supply-chain logistics, a transformed marketing message, and the search for more promising new products, Procter & Gamble is positioning itself to see its stock do better and reward patient investors for their loyalty.",0.9428035616874695,0.017763294279575348,0.03943314403295517,positive,0.9250402450561523
20,2018-05-18 07:13:00,"Finally, Merck is the lowest-yielding stock of this group of three, yet even it manages to post a 3.2% yield from its dividend.",0.09542679786682129,0.8362817764282227,0.06829143315553665,negative,-0.7408549785614014
21,2018-05-18 07:13:00,The drugmaker has several well-known medications that produce a ton of cash flow.,0.4250861704349518,0.01143998745828867,0.5634738206863403,neutral,0.4136461913585663
22,2018-05-18 07:13:00,"And even though the many clinical trials in its pipeline are expensive, Merck has enough capital to reinvest in its business and still leave plenty behind for dividend payments.",0.7153412699699402,0.017118282616138458,0.26754048466682434,positive,0.6982229948043823
23,2018-05-18 07:13:00,"Merck hasn't been as reliable as its peers in dividend growth, but for seven straight years now, shareholders have seen rising payouts on an annual basis.",0.9313506484031677,0.023793311789631844,0.044856004416942596,positive,0.9075573086738586
24,2018-05-18 07:13:00,Merck has seen a lot of changes recently in where it gets revenue from its core pharma business.,0.3447599411010742,0.011343792080879211,0.6438962817192078,neutral,0.3334161639213562
25,2018-05-18 07:13:00,"Blockbuster treatments like Januvia and Janumet for diabetes have faced pressure on the pricing front, while cardiovascular drugs Vytorin and Zetia have had to deal with greater competition from generics.",0.03155668079853058,0.9396028518676758,0.028840478509664536,negative,-0.9080461859703064
26,2018-05-18 07:13:00,Yet Merck has seen some other drugs step up to provide the growth to offset sales declines elsewhere.,0.9235640168190002,0.014987334609031677,0.06144863739609718,positive,0.9085766673088074
27,2018-05-18 07:13:00,"For example, cancer-fighter Keytruda has been a promising high-growth drug, and Merck hopes to get Food and Drug Administration approval for its use in a wider range of illnesses.",0.8165289163589478,0.01357523538172245,0.16989588737487793,positive,0.8029536604881287
28,2018-05-18 07:13:00,The drugmaker has also made a big boost in research-and-development spending to build out its pipeline of future candidate treatments.,0.9359742999076843,0.015612957999110222,0.04841279238462448,positive,0.920361340045929
29,2018-05-18 07:13:00,"All told, Merck isn't shying away from the challenge of reinvesting in its own business, and similar strategies have worked out well in the past.",0.7042906880378723,0.014110858552157879,0.28159844875335693,positive,0.6901798248291016
30,2018-05-18 07:13:00,"Get the income you need

Dividend stocks aren't free of risk, but they can provide the income you need as well as opportunities for share-price appreciation.",0.3603633642196655,0.010642080567777157,0.6289945840835571,neutral,0.3497212827205658
31,2018-05-18 07:13:00,"Merck, Procter & Gamble, and Chevron all have the potential to see good total returns for the foreseeable future, and those gains could come sooner rather than later if the companies can execute well on their business opportunities.",0.9446185827255249,0.016876591369509697,0.038504790514707565,positive,0.9277420043945312
32,2018-05-18 07:13:00,10 stocks we like better than Merck & Co.,0.4072535037994385,0.02517339400947094,0.5675731301307678,neutral,0.3820801079273224
33,2018-05-18 07:13:00,"When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12617750465869904,0.07430703938007355,0.799515426158905,neutral,0.05187046527862549
34,2018-05-18 07:13:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
35,2018-05-18 07:13:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Merck & Co. wasn't one of them!",0.21005313098430634,0.016412779688835144,0.7735341191291809,neutral,0.1936403512954712
36,2018-05-18 07:13:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
37,2018-05-18 07:13:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
38,2018-05-18 07:13:00,"*Stock Advisor returns as of May 8, 2018

Dan Caplinger has no position in any of the stocks mentioned.",0.009967850521206856,0.03234436735510826,0.9576878547668457,neutral,-0.022376516833901405
39,2018-05-18 07:13:00,The Motley Fool has no position in any of the stocks mentioned.,0.011856832541525364,0.05262438580393791,0.9355188012123108,neutral,-0.04076755419373512
40,2018-05-18 07:13:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
41,2018-05-18 07:13:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
